Vaxcyte, Inc. filed 3 current reports with the SEC under Item 5.02, which covers directors and officers leaving or being appointed, the latest on 2026-09-03. Between them they name 4 people, with 2 appointments and 2 departures. Each change below is quoted from the filing and linked to it.
Every change, newest first
Reported
On August 31, 2026, Vaxcyte, Inc. (the "Company") appointed David McAvoy as the Company's Chief Legal Officer, Chief Compliance Officer, and Corporate Secretary.
Departing: Heath Lukatch, effective 2026-07-16
On July 13, 2026, Heath Lukatch notified the Board of Directors (the "Board") of Vaxcyte, Inc. ("the "Company") of his retirement from the Board, effective as of July 16, 2026.
Appointed: John Markels, Director, effective 2026-07-16
Concurrently, upon recommendation of the Nominating and Corporate Governance Committee of the Board, the Board appointed John Markels to the Board as a Class II director, effective as of July 16, 2026.
Departing: Jacks Lee, effective 2026-06-17
On June 17, 2026, Jacks Lee notified the Board of Directors (the "Board") of Vaxcyte, Inc. ("the "Company") of his retirement from the Board, effective as of June 17, 2026.
Appointed: Moncef Slaoui, Director
On June 17, 2026, upon recommendation of the Nominating and Corporate Governance Committee of the Board, the Board appointed Moncef Slaoui to the Board as a Class II director, which appointment became effective immediately.
Find people with the same kind of experience as the Director at Vaxcyte, Inc., with the record behind each one.
Find candidates like Director at Vaxcyte, Inc.New leaders review vendors and budgets in their first months. Get an alert the next time Vaxcyte, Inc. is in the news or changes leadership.
Get an alert when Vaxcyte, Inc. changes leadershipTools for this story
Each opens in a new tab, filled in for Vaxcyte, Inc.. With no account yet, you sign up free and land on the result.
Where this comes from
A public company must file a current report on Form 8-K with the SEC within four business days when a director leaves or is elected, or when its chief executive, chief financial, chief accounting or chief operating officer, or another named executive, departs or is appointed. That disclosure goes under Item 5.02 of the report.
Every change on this page is taken from one of those filings and quoted in the company's own words, with a link to the filing, so it can be checked at the source. Where a filing names the person, the role and the date a change takes effect, they are shown beside the quote. Where it does not, the quote stands on its own. A filing states what changed; it rarely states why, and neither does this page.